Alembic Profit & Loss Annual

Trade
BSE: 506235 | NSE: ALEMBICLTD | ISIN: INE426A01027 | Sector: Biotechnology & Drugs
91.24 -1.79 (-1.92%)Updated : 18 Apr 2024
Fiscal Period2023202220212020
Period End DateMar 23Mar 22Mar 21Mar 20
Revenue 127.2478.2273.5273.93
Total Revenue 127.2478.2273.5273.93
Costof Revenue Total 45.0225.0824.2934.07
Gross Profit 82.2253.1449.2239.85
Selling/ General/ Admin Expenses Total 40.1837.5136.5835.41
Depreciation/ Amortization 1.731.781.511.28
Interest Exp( Inc) Net- Operating Total 49.9530.8224.2719.49
Unusual Expense( Income) 10.61-0.37--
Other Operating Expenses Total 1.711.701.581.16
Total Operating Expense 104.2468.7866.3973.87
Operating Income 23.009.447.130.05
Interest Inc( Exp) Net- Non- Op Total 598.88820.0061.08895.58
Gain( Loss)on Saleof Assets 10.2619.582.445.05
Other Net 2.884.463.563.05
Net Income Before Taxes 86.8097.8617.0493.17
Provisionfor Income Taxes 6.1811.663.200.13
Net Income After Taxes 80.6286.1913.8493.03
Equity In Affiliates 1,100.301,358.653,290.042,360.84
Net Income Before Extra Items 190.65222.06342.84329.12
Net Income 190.65222.06342.84329.12
Income Availableto Com Excl Extra Ord 190.65222.06342.84329.12
Income Availableto Com Incl Extra Ord 190.65222.06342.84329.12
Diluted Net Income 190.65222.06342.84329.12
Diluted Weighted Average Shares 25.6825.6825.6825.68
Diluted EPS Excluding Extra Ord Items 7.428.6513.3512.82
DPS- Common Stock Primary Issue 2.201.800.200.60
Diluted Normalized EPS 7.778.5713.3412.80
Total Adjustmentsto Net Income ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,267.20+50.50(4.15%)
1,420.55+5.80(0.41%)
3,526.40-120.65 (-3.31%)
2,462.75-84.40 (-3.31%)